325
1855582226014562116175
Ces37037936014570127174
Urol39027936014578115180208
2022;41357936014562121178238261
26(3):44217936014562120153211240262
174–18547087936014562113165228281336395
PŘEHLEDOVÉ3674207016974156235334409485586692777855
ČLÁNKY4568207016989162260360444533
32.624896013356109132
Arends779896013372107161222284327
TJH,112989601335892164187
Nativ1339896013377129165190242
O,160589601337999
Maffezzini1727896013392145177209264311361386446471
M,2222896013392116
et236189601335996
al.248089601335782105
Results2608898013160113153209231265306
of293889801316391
the305389801313896150
first32278980131305788129163
randomized341489801313787144204262352373417469529
controlled3967898013153109168199231288311332385446
trial44378980131386992140162
comparing4623898013154109199259309340362420479
intravesical624104801312379110141190237288327348395444466
radiofrequency1113104801312877135157213241273324383439491548595645
induced1782104801311975133189237287346
chemohyperthermia21521048013144101153241298356401461514544580637690720809830877
with3053104801317496129186
mitomycin‑C32621048013185106139194282327374395452485549
vs3835104801314584
BCG39621048013151112174
for4160104801312480112
adjuvant42951048013145104125181230279335366
treatment4685104801312960111158189277330387418
of624119801315987
patients7351198013161111143165217275307349
with11081198013179102135193
intermediate‑and1325119801312381113164195285338398420469501552586635693752
high‑risk2101119801315981140198231264287326371
non‑muscle24961198013159117175209299356396444467519
invasive3039119801312381128178218239288340
bladder3403119801316184133192251304336
cancer3763119801314999156205256287
Eur40881198013152107138
Urol42501198013169100157180
2015;44721198013154105153198213
14:47091198013153100117
e94448501198013153106160217
33.6241346013356110131
Colombo7781346013361119145206297359420
R,1221134601335681
Salonia13251346013351104130190251276328
A,1676134601336489
Leib17881346013349103129191
Z,2002134601335780
et2106134601335188
al.221713460133507598
Long23381348013146103161221
term2583134801313081113203
outcomes28101348013155113146192248338391431
of3266134801315583
a33731348013147
randomized3444134801312979137196254344365409461521
controlled39891348013146102160192224280303325378438
trial445113480131316385133156
comparing46311348013145101191251301332354412471
thermochemotherapy624149801313492145177266325374432485574632665723776807857917964
with16121498013187110143201
mitomycin18371498013197119153209298344392414471
C23321498013170
alone2426149801315880138196250
as2700149801315797
adjuvant28211498013157117139196245295353384
treatment3229149801314274125173205295348406438
for3691149801313693125
non38401498013166125183
muscle40471498013198155194243265318
invasive4389149801313088135185225246295347
bladder4760149801316891140199259312343
cancer624164801314999157205256287
(NMIBC)936164801312997182204259321351
BJU1326164801315692160
Int1510164801312481113
2011;16661648013154105153194204
107:18951648013153100149163
912–91820821648013154102147198251299346
34.6241796013356112134
Arends782179601336398152213274317
TJ,1122179601335184105
Nativ12501796013369121156181233
O,1507179601337191
Maffezzini16211796013385137169201255302352377437461
M,21061796013384108
et2237179601335187
al.234817960133497496
Results24681798013152104144201223255297
of2789179801315483
a28961798013146
randomised2965179801312979136195253342364403456515
controlled35041798013146101159191222279302323376436
trial396417980131306184132154
comparing41421798013145100190249299330352409468
intravesical4634179801311977108140189237288328349397447469
chemohyperthermia6241948013149106159248306364410471524556592650703734824845893
with1541194801317698131189
mitomycin17541948013186108141197286332379401458
C22361948013159
versus2319194801314597128169225264
bacillus26071948013157107155176198220276316
Calmette29461948013159109131219272305341392
Guérin33621948013164122175206228286
for3672194801312581113
adjuvant38091948013146105127184233283340372
treatment4205194801313061113161192282334392424
of4653194801315482
patients47591948013157107139161213271302344
with6242098013179102135193
Intermediate-841209801312481113164196286339399421469501552587
and14522098013150108167
High1643209801316991150208
risk187520980131335594139
Non20382098013170129187
Muscle22492098013186143183232254306
invasive2580209801312280127177217238287339
Bladder2943209801315679127187246299330
Cancer32982098013162112170218269301
Eur36372098013151106138
Urol3799209801316899156179
2016;40202098013154106153200217
69(6):42612098013154105134184210227
1046–105245122098013154101156211269315362414464
35.6242246013356109130
van7772246013349102162
Valenberg9622246013358108133188248310366401462
FJP,1447224601335080139148
Kajtazovic16182246013356110135171224271331382408456
A,2098224601336388
Canepa22092246013360113173228290343
G,2575224601336791
et2689224601335288
al.280022460133507597
Intravesical2921224801311977109140190237289329350399448470
Radiofrequency‑Induced3415224801315210116118224026830135241246952258062867971273679385391095810091069
Chemohyper‑45082248013159116169258316374420481535566595
thermia624239801313492145177266288337
for985239801313088120
Carcinoma11292398013164114145192214271330419468
in1621239801312583
Situ1728239801315374107165
of1917239801316189
the2030239801313694147
Urinary22012398013171102125182231262314
Bladder:2539239801315880129188248301332352
A29152398013166
Retrospective30062398013157110143175232272331385434470492542594
Multicentre36242398013187145167200222270321379411443494
Study4142239801315384142202250
Bladder4429239801315881129189248301332
Cancer47862398013164114172220271303
2018;6242548013154105153199216
4(4):865254801315382132157174
365–37610632548013153105157212260309357
36.6242696013356112134
Tan7822696013358104164
WS,9692696013397151173
Panchal11662696013362114174223283336361
A,1550269601337296
Buckley16702696013363123173223250305356
L,2049269601335680
et2152269601335996
al.2271269601335782105
Radiofrequency‑induced2399269801316010916919124827731036142147953258963868972174580286291996710181078
Thermo‑chemotherapy350226980131551151681992893483834344915446336927247828358679179761023
Effect4549269801315684114166215251
Versus48242698013160110141182239278
a6242848013150
Second6982848013147100149205264323
Course10452848013159115172204244297
of1366284801315583
Bacillus14732848013152102150172194215272311
Calmette‑Guérin18082848013159109131219272305342392427498556609640663720
or2552284801315587
Institutional2663284801311977116150172205263296318376434483505
Standard3192284801314778128185245293324382
in3598284801311977
Patients3699284801315199131153205263295336
with4059284801317698132189
Recurrence42722848013152105154212243275326384433483
of4779284801315583
Non­48862848013167125183217
‑muscle‑invasive6242998013133123180220268290343378401459506556596617666718
Bladder1366299801315881129189248301332
Cancer17222998013165115173221272304
Following20502998013153110133154212291313371430
Induction2504299801312683143200248285307364423
or2951299801316193
Maintenance30682998013188137159216248299357405463512563
Bacillus36552998013158108156178200222278318
Calmette‑Guérin39972998013165115137225278312348399433505563616647670727
Therapy47482998013154114167198248308355
(HYMN):624314801312997151236305333349
A9983148013164
Phase10863148013155112161200254
III,13643148013123456785
Open‑label,14733148013174134188246280304352412466489506
Randomised20033148013156105163222280370392431484544
Controlled25713148013163119178209241298321343395456
Trial305131480131517598146169
Eur32623148013151107138
Urol34243148013169100156179
2019;36463148013153105153198216
75(1):38863148013154103129176196213
63–7141233148013154105160207256
37.6243296013356109120
Sri767329601335388113
D,904329601337191
Lee10183296013350104160
HJ,12013296013371111133
El‑Gemmal1357329601335377112186242334425477503
S,1883329601335375
et1982329601335390
al.209532960133517799
Cystectomy22183298013161102143178229278314370460506
outcomes27483298013157115149195251340393434
in3206329801312179
patients33093298013159109141163216273305347
who36803298013178136195
have38993298013157106153205
failed4128329801312778100122175235
Radiofrequency­43873298013154103163185242271304355415473525583632683716
‑induced624344801313356113173230278329389
Thermo‑chemotherapeutic1037344801314810716019228134037442548353662568371577382685890796710211078111111331182
Effect2243344801314775105157206242
Mitomycin‑C25093448013182104137193283329376398455488554
(RITE‑MMC)3087344801312580103154206237324408470500
treatment3611344801313162114162194283336394425
for4060344801312683115
high‑risk4199344801315576135193226259281320365
non‑muscle45883448013155113172205295352392440462515
invasive624359801312381128178217239288340
bladder988359801316286134194253306337
cancer13493598013152101159208258290
(HRNMIBC)1663359801313199153223308330385447477
–21643598013157
Does22453598013174132186227
it2496359801312558
complicate25783598013151107197256279301349399431482
surgery30843598013143100131189242273325
and34333598013152110169
adversely36263598013152112161213244285338361409
impact40593598013125114173223272308
oncological43913598013160119168223247305365387435485507
out‑49223598013160118152181
come?6243748013149105195248285
Urol933374801316999156179
Oncol11363748013174133181237260
2021;14393748013154105155202212
39(5):16753748013154104132183210227
30019263748013153106161
e15–3002104374801315397142197246298353
e2024753748013153105157
Soutěž1984464604151853775736988741031
ČUS308146460415198423604
o375146460415194
nejlepší40104646041519837447356874594610931189
původní19844996041520139757776396311601255
vědeckou330449960415182351554730878106912561452
práci482149960415201333509655752
publikovanou19845392026112123635439843952864073583394710621176
v320853920261100
časopise33565392026198196273388507551627731
Česká413653920261125225304392493
urologie467753920261117177289333448567609712
2022480956480474195387572768
Všechny23246543017876133206274354433497
původní28556543017884164232311394473503
vědecké33936543017869140223296364427498
práce39256543017884129198265335
publikované42946543017884164246279309371449516584664737
v23246743017868
časopise24266743017869137192272355386440513
Česká29746743017887157213275345
urologie33536743017881125202235314397428500
v38886743017869
roce39916743017846124192262
202242886743017874145213286
budou46086743017885165247326406
do23246943017882162
soutěže25206943017857137217264334395465
zařazeny30206943017862132175243305376456519
automaticky.35736943017870149195272395462507538604667738757
Podmínkou23247143017875152235357387467529608687
zařazení30467143017862132175243305376456486
je,35667143017834106130
že37307143017862133
první38977143017884129202283313
autor42457143017869148194271316
bude45957143017884164246319
urolog.49487143017882125203235315398424
Vítězné23247428017876108154224285366439
práce27987428017884128197264334
budou31677428017884164246326405
vyhlášeny36077428017869141222253320375448527591
na23247628017880148
Výroční25067628017878146191269337417447
konferenci29877628017865143224262334378449528595626
ČUS36477628017887179245
2023.39277628017874145214286311
Následně23247913017896163218249321404484557
budou29157913017884165246326406
výsledky33557913017870142198228301384447518
zveřejněny39097913017860133204247318349428501580644
v45877913017869
časopisu46917913017868136191271354386440517
Česká23248113017886156211273344
urologie27028113017881124202234314397428500
a32368113017870
na33408113017882149
webových352481130178110181264345412483549628
stránkách41878113017857105149218297360430497577
ČUS.47988113017887179245272
Soutěž32067410327146300457559701828
ČUS120267410327159340485